Download to read offline
Uploaded byClive Bates
FDLI Annual 2024: seven reasons why the litigation will never stop
The document discusses the complexities surrounding litigation in the vaping industry, outlining seven reasons for ongoing legal challenges, including evidential burdens, opaque success criteria, and poor market surveillance. It highlights the differences in smoking and vaping prevalence among youth and adults, emphasizing the need for accurate assessments of vaping's impact on public health. The content is part of the agenda for the 2024 FDLI Annual Conference taking place in Washington, DC, and virtually.
FDLI Annual 2024: seven reasons why the litigation will never stop
- 1. May 15–16, 2024| Washington, DC & Virtual CONNECT WITH FDLI #FDLIAnnual24 2024 FDLI Annual Conference Seven reasons why the litigation will never stop Clive Bates Counterfactual Consulting London, United Kingdom
- 2. Seven reasons fortrouble in the courts 1. Evidential burdens 2. Opaque success criteria 3. Defining APPH 4. Naivety about youth 5. De facto standard setting 6. Assessing products in isolation 7. Poor market surveillance
- 3. Seven reasons fortrouble in the courts 1. Evidential burdens 23 vaping products FDA Authorized E-Cigarette Products 300,000 vaping products COM(2021) 249 final
- 4. Seven reasons fortrouble in the courts 1. Evidential burdens 2. Opaque success criteria
- 5. Seven reasons fortrouble in the courts 1. Evidential burdens 2. Opaque success criteria 3. Defining APPH Risks Benefits Adolescents Adults Uptake of vaping by adolescents who would otherwise never use nicotine. Uptake by never- smokers or former smokers Switching from cigarettes & diversion from smoking uptake Smoking cessation or reduction, better health & wellbeing
- 6. Seven reasons fortrouble in the courts 1. Evidential burdens 2. Opaque success criteria 3. Defining APPH 0 5 10 15 20 25 30 35 40 Youth (NYTS) Adults (NHIS) Million Americans Smoking and vaping in 2021 Millions of Americans Source: National Youth Tobacco Survey (NYTS) 2021 data, National Health Interview Survey (NHIS) 2021 data. Graphic by Clive Bates. With thanks to Brad Rodu for data extraction and cross-tabulations. Smoking Vaping only Dual use Nearly all the attention goes here The public health problem is here
- 7. Seven reasons fortrouble in the courts 1. Evidential burdens 2. Opaque success criteria 3. Defining APPH 4. Naivety about youth Infrequent vaping Mostly experimental, or frivolous use More committed use
- 8. Seven reasons fortrouble in the courts 1. Evidential burdens 2. Opaque success criteria 3. Defining APPH 4. Naivety about youth
- 9. Seven reasons fortrouble in the courts 1. Evidential burdens 2. Opaque success criteria 3. Defining APPH 4. Naivety about youth Smoking & vaping prevalence (%) Americans aged 18-24. National Health Interview Survey, 2014-2022 Did not smoke before vaping Vaping former smokers Smoking & vaping Smoking only >70% reduction in smoking, >80% reduction in exclusive smoking
- 10. Seven reasons fortrouble in the courts 1. Evidential burdens 2. Opaque success criteria 3. Defining APPH 4. Naivety about youth 5. De facto standard setting
- 11. Seven reasons fortrouble in the courts 1. Evidential burdens 2. Opaque success criteria 3. Defining APPH 4. Naivety about youth 5. De facto standard setting 6. Assessing products in isolation Rest of the market New product
- 12. Seven reasons fortrouble in the courts 1. Evidential burdens 2. Opaque success criteria 3. Defining APPH 4. Naivety about youth 5. De facto standard setting 6. Assessing products in isolation 7. Poor market surveillance
- 13. Seven reasons fortrouble in the courts 1. Evidential burdens 2. Opaque success criteria 3. Defining APPH 4. Naivety about youth 5. De facto standard setting 6. Assessing products in isolation 7. Poor market surveillance
- 14. May 15–16, 2024| Washington, DC & Virtual CONNECT WITH FDLI #FDLIAnnual24 2024 FDLI Annual Conference Thank you Clive Bates Counterfactual Consulting London, United Kingdom [email protected] @clive_bates clivebates.com